Early Clinical and CT Manifestations of Coronavirus Disease 2019 (COVID-19) Pneumonia

Tissue-resident CD8+T cells drive age-associated chronic lung sequelae following viral pneumonia

“…Indeed, lung fibrosis is well-documented in a substantial number of patients who have recovered from the infection of SARS-CoV or MERS-CoV [68, 69] and a group of influenza patients with severe acute diseases [20]. Emerging evidence has also suggested that COVID-19 survivors will likely exhibit persistent impairment of lung function and the development of pulmonary fibrosis [21, 70-74]. Data presented here suggests for the first time that excessive T RM cells are likely the cause of chronic lung diseases and pulmonary fibrosis following viral pneumonia in aged individuals.…”

Lung cancer management challenges amidst COVID-19 pandemic: hope lives here

“…All lung cancer patients scheduled for anticancer treatment must be tested for COVID-19, irrespective of symptoms or contact history, to determine the status before compromising their immune system. Unfortunately, testing kits are not readily available [4].…”

Contrast enhanced ultrasonography (CEUS) to detect abdominal microcirculatory disorders in severe cases of COVID-19 infection: First experience

“…First publications showed that COVID-19 patients often suffer from pneumonia [1][2][3] and pulmonary changes monitored by ultrasound [4,5]. Older age, showing signs of sepsis on admission, underlying diseases like high blood pressure and diabetes and the prolonged use of noninvasive ventilation were important factors on the deaths of these patients [2].…”